Protocol Compliance [GxP / QC / QA]

posted by Dr.Sridhar – 2010-04-03 13:04 (5918 d 08:36 ago) – Posting: # 5007
Views: 6,969

Dear Raghavendra,

It will be better to safety analysis to be on safer side because this will prove that subject lost to follow up was due to his personal problems or not due to any Adverse event with your drug.

And you can also file an protocol deviation for same with proper explanation.

Regards,
Dr.Sridhar


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
136 visitors (0 registered, 136 guests [including 10 identified bots]).
Forum time: 21:40 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5